OA
Oak Associates Portfolio holdings
AUM
$1.53B
1-Year Return
20.93%
This Quarter Return
+8.55%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.69B
AUM Growth
+$36.1M
(+2.2%)
Cap. Flow
-$72.6M
Cap. Flow
% of AUM
-4.3%
Top 10 Holdings %
Top 10 Hldgs %
46.67%
Holding
141
New
4
Increased
51
Reduced
46
Closed
6
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$8.79M |
| 2 |
M/I Homes
MHO
|
$4.04M |
| 3 |
Salesforce
CRM
|
$2.67M |
| 4 |
Taylor Morrison
TMHC
|
$2.45M |
| 5 |
Cencora
COR
|
$2.06M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$22.3M |
| 2 |
KLA
KLAC
|
$12M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$11.4M |
| 4 |
Apple
AAPL
|
$9.49M |
| 5 |
HP
HPQ
|
$7.7M |
Sector Composition
| 1 | Technology | 39.09% |
| 2 | Communication Services | 15.19% |
| 3 | Consumer Discretionary | 14.55% |
| 4 | Healthcare | 13.65% |
| 5 | Financials | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Global Payments
GPN
$21.2B
| $20.5M | 1.21% |
101,692
+10
| +0% | +$2.02K |
|
27
Zimmer Biomet
ZBH
$20.8B
| $20.3M | 1.2% |
130,673
+7,046
| +6% | +$1.1M |
|
28
Alcon
ALC
$39B
| $18.8M | 1.11% |
267,399
-42,350
| -14% | -$2.97M |
|
29
Novartis
NVS
$249B
| $18.5M | 1.09% |
216,328
-23,099
| -10% | -$1.97M |
|
30
Labcorp
LH
$22.9B
| $18.2M | 1.08% |
83,267
+1,036
| +1% | +$227K |
|
31
Akamai
AKAM
$11.1B
| $15.4M | 0.91% |
151,140
| – | – |
|
|
32
Salesforce
CRM
$232B
| $15.2M | 0.9% |
71,800
+12,595
| +21% | +$2.67M |
|
33
Cognizant
CTSH
$34.9B
| $14.9M | 0.88% |
190,683
+10,758
| +6% | +$840K |
|
34
DraftKings
DKNG
$23.5B
| $13.9M | 0.82% |
226,560
-175
| -0.1% | -$10.7K |
|
35
Accenture
ACN
$158B
| $13.2M | 0.78% |
47,902
+5
| +0% | +$1.38K |
|
36
Illumina
ILMN
$15.5B
| $13.1M | 0.78% |
35,077
-3,737
| -10% | -$1.4M |
|
37
Gentex
GNTX
$6.17B
| $12.1M | 0.72% |
340,375
-1,605
| -0.5% | -$57.3K |
|
38
NetApp
NTAP
$23.7B
| $12.1M | 0.72% |
166,785
+20
| +0% | +$1.45K |
|
39
McKesson
MCK
$86B
| $11.5M | 0.68% |
58,811
-66
| -0.1% | -$12.9K |
|
40
Pfizer
PFE
$140B
| $11.5M | 0.68% |
316,036
-205,047
| -39% | -$7.43M |
|
41
PayPal
PYPL
$65.4B
| $11M | 0.65% |
45,346
-69
| -0.2% | -$16.8K |
|
42
State Street
STT
$32.4B
| $10.1M | 0.6% |
119,984
+12,414
| +12% | +$1.04M |
|
43
Gilead Sciences
GILD
$140B
| $8.93M | 0.53% |
138,229
+20,289
| +17% | +$1.31M |
|
44
Medtronic
MDT
$119B
| $8.7M | 0.51% |
73,626
+15
| +0% | +$1.77K |
|
45
Intuitive Surgical
ISRG
$163B
| $8.68M | 0.51% |
35,256
+4,446
| +14% | +$1.1M |
|
46
Check Point Software Technologies
CHKP
$20.5B
| $8.41M | 0.5% |
75,143
-25,000
| -25% | -$2.8M |
|
47
Amdocs
DOX
$9.31B
| $7.99M | 0.47% |
113,904
-853
| -0.7% | -$59.8K |
|
48
Assurant
AIZ
$10.9B
| $6.33M | 0.37% |
44,620
+270
| +0.6% | +$38.3K |
|
49
GSK
GSK
$79.8B
| $6.08M | 0.36% |
136,300
-18,636
| -12% | -$831K |
|
50
Bank of New York Mellon
BK
$74.4B
| $6.07M | 0.36% |
128,300
-1,225
| -0.9% | -$57.9K |
|